<DOC>
	<DOCNO>NCT03023293</DOCNO>
	<brief_summary>The purpose study clarify relationship n-3 PUFA irisin regulate glucose metabolism GDM patient .</brief_summary>
	<brief_title>Effects Mechanisms n-3 PUFAs Irisin Incidence Abnormal Glucose Metabolism After GDM</brief_title>
	<detailed_description>Gestational diabetes mellitus ( GDM ) important risk factor type 2 diabetes woman . Studies show n-3 polyunsaturated fatty acid ( n-3 PUFA ) associate improve insulin resistance prevent type 2 diabetes general population ; newly discover myokine , irisin , associate reduced insulin resistance play important role human glucose metabolism ; result cell study suggest n-3 PUFA might increase expression irisin . Therefore , investigator hypothesize n-3 PUFA could improve glucose metabolism via IRS-1/PI3K/AKT insulin signal pathway increase expression irisin thus improve postpartum glucose metabolism woman GDM . In order test hypothesis , investigator plan establish prospective GDM cohort collect relate information 24-28 week ' gestation , 42 day postpartum , 1 year postpartum 2 year postpartum , respectively . Then follow would test : change n-3 PUFA irisin pregnancy delivery , association postpartum abnormal glucose metabolism ; correlation n-3 PUFA irisin . Furthermore , use cell model insulin resistance investigator would examine dose-response time-response relationship n-3 PUFA irisin , next explore role irisin n-3 PUFA regulation IRS-1/PI3K/AKT insulin signal pathway . This study would help clarify relationship n-3 PUFA irisin regulate glucose metabolism , might provide scientific evidence prevention type 2 diabetes GDM .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<criteria>Pregnant woman gestational diabetes mellitus screen The Guidelines diagnosis treatment gestational diabetes mellitus China 2014. age &lt; 20 year â‰¥ 45 year ; woman diabetes , cardiovascular disease , thyroid disease , blood disease polycystic ovary syndrome pregnancy ; multiple pregnancy assist reproductive technology pregnancy ; woman severe postpartum endocrine disorder disease , pancreatitis , hyperthyroidism , nephritis ; infection pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>n-3 polyunsaturated fatty acid</keyword>
	<keyword>irisin</keyword>
</DOC>